Basel Medical (BMGL) Cash & Equivalents (2024 - 2025)
Basel Medical (BMGL) posted Cash & Equivalents of $3.0 million for Q4 2025, up 30.17% sequentially from $2.3 million in Q2 2025, and up 56.04% YoY from $2.0 million in Q4 2024.
Basel Medical (BMGL) Cash & Equivalents (2024 - 2025) Analysis & Trends
Basel Medical has reported Cash & Equivalents for 2 years, with the latest figure at $3.0 million in Q4 2025.
- Quarterly Cash & Equivalents rose 56.04% year-over-year to $3.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.0 million (up 56.04% YoY) and the FY2025 annual result came in at $2.3 million, up 119.97% from the prior year.
- Cash & Equivalents grew to $3.0 million in Q4 2025 per BMGL's latest filing, from $2.3 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $3.0 million in Q4 2025 and troughed at $1.4 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | 1.01 Bn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 2.17 Bn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | 107.70 Mn |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 668.96 Mn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 262.30 Mn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 138.80 Mn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 164.45 Mn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 40.22 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 158.04 Mn |
| 10 | Basel Medical | 98.81 Mn | 98.02 Mn | - | 3.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.04 Mn |
| Jun 30, 2025 | 2.34 Mn |
| Dec 31, 2024 | 1.95 Mn |
| Jun 30, 2024 | 1.44 Mn |